The data from the Phase 1/1b clinical trial of soquelitinib in patients with T cell lymphoma continues to demonstrate strong indications of anti-tumor activity in a significant number of patients,” ...
A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of ...
4d
News-Medical.Net on MSNSemi-synthetic bile acid could be a promising therapeutic option for TH17-mediated intestinal diseasesA research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.
T cells are white blood cells that are important for adaptive immunity. They have unique cell surface receptors that are generated by randomly assorting genes. These receptors allow T cells to ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
8d
News-Medical.Net on MSNNatural ingredient gluconolactone offers hope for targeted lupus therapyLupus is an autoimmune disease where the body’s immune system attacks its own tissues and organs, causing inflammation and damaging organs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results